Xinzhou Li serves as Executive at NovaBay Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Xinzhou Li has executed 5 insider transactions totaling $2.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 20, 2013 involved selling 120,000 shares valued at $224.4K.
Xinzhou Li currently holds 2,001,743 shares of NovaBay Pharmaceuticals, Inc. (NBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Xinzhou Li has been a net buyer of NBY stock. They have purchased $2.6M and sold $224.4K worth of shares.
Xinzhou Li's most recent insider trade was on Sep 20, 2013, when they sold 120,000 shares at $1.87 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 11, 2012 | NBY | $144.0K | Purchase | 120,000 | $1.20 | Discretionary |
| Oct 31, 2012 | NBY | $1.5M | Purchase | 1,200,000 | $1.25 | Discretionary |
| Sep 13, 2012 | NBY | $1.0M | Purchase | 800,000 | $1.25 | Discretionary |